NRL-1

· Neurelis, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NRL-1, covering 2021-10-05 to 2022-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects [Phase 3]